Xeris Biopharma Holdings Inc (XERS)

2.87 +0.04 (+1.41%) USD  |  NASDAQ  |  Sep 27, 16:00
2.87 0.00 (0.00%) After-Hours: 20:00
More

Xeris Biopharma Holdings EBITDA Estimates for Current Quarter

EBITDA Estimates for Current Quarter Chart

View EBITDA Estimates for Current Quarter for XERS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical EBITDA Estimates for Current Quarter Data

View and export this data back to 2022. Upgrade now.
Date Value
August 12, 2024 --
May 13, 2024 --
Date Value
March 20, 2024 --
November 09, 2022 --

EBITDA Estimates for Current Quarter Range, Past 5 Years

Upgrade
Minimum
Nov 09 2022
Upgrade
Maximum
Aug 12 2024
Upgrade
Average
Upgrade
Median

EBITDA Estimates for Current Quarter Benchmarks

Zoetis Inc Upgrade
Zevra Therapeutics Inc Upgrade
NovaBay Pharmaceuticals Inc Upgrade
Palatin Technologies Inc Upgrade
iBio Inc --